Increasing lysergic acid levels for ergot alkaloid biosynthesis: Directing catalysis via the F-G loop of Clavine oxidases
暂无分享,去创建一个
[1] K. Berka,et al. Membrane-attached mammalian cytochromes P450: An overview of the membrane's effects on structure, drug binding, and interactions with redox partners. , 2018, Journal of inorganic biochemistry.
[2] Yanxing Jia,et al. Ergot alkaloids: synthetic approaches to lysergic acid and clavine alkaloids. , 2017, Natural product reports.
[3] Heidi J. Imker,et al. Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating protein sequence similarity networks. , 2015, Biochimica et biophysica acta.
[4] Michael J E Sternberg,et al. The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.
[5] D. Panaccione,et al. Heterologous Expression of Lysergic Acid and Novel Ergot Alkaloids in Aspergillus fumigatus , 2014, Applied and Environmental Microbiology.
[6] Emad Tajkhorshid,et al. Characterizing the Membrane-Bound State of Cytochrome P450 3A4: Structure, Depth of Insertion, and Orientation , 2013, Journal of the American Chemical Society.
[7] Jens Nielsen,et al. Identification and treatment of heme depletion attributed to overexpression of a lineage of evolved P450 monooxygenases , 2012, Proceedings of the National Academy of Sciences.
[8] P. Schiff. Ergot and its alkaloids. , 2006, American journal of pharmaceutical education.
[9] P. Tudzynski,et al. Identification of the Cytochrome P450 Monooxygenase that Bridges the Clavine and Ergoline Alkaloid Pathways , 2006, Chembiochem : a European journal of chemical biology.
[10] C. Machado,et al. The ergot alkaloid gene cluster in Claviceps purpurea: extension of the cluster sequence and intra species evolution. , 2005, Phytochemistry.
[11] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[12] S. Agurell,et al. Biogenetic interrelationships of ergot alkaloids. , 1962, Archives of biochemistry and biophysics.
[13] A. Pontecorvi,et al. Hyperprolactinemia: pathophysiology and therapeutic approach , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[14] S. Bell,et al. The structure of CYP101D2 unveils a potential path for substrate entry into the active site. , 2011, The Biochemical journal.
[15] B. Winblad,et al. Therapeutic Use of Nicergoline , 2008, Clinical drug investigation.
[16] R. Schiestl,et al. Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method , 2007, Nature Protocols.
[17] Soo-Un Kim,et al. Microsomal agroclavine hydroxylase of Claviceps species , 1981 .
[18] John A. D. Anderson,et al. Agroclavine hydroxylase of Claviceps purpurea , 1970 .